The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease

被引:1
|
作者
Ribeiro, Felipe C. [1 ]
Cozachenco, Danielle [1 ]
Argyrousi, Elentina K. [2 ]
Staniszewski, Agnieszka [2 ]
Wiebe, Shane [3 ]
Calixtro, Joao D. [1 ]
Soares-Neto, Rubens [1 ]
Al-Chami, Aycheh [4 ]
El Sayegh, Fatema [4 ]
Bermudez, Sara [3 ]
Arsenault, Emily [4 ]
Cossenza, Marcelo [5 ]
Lacaille, Jean-Claude [6 ,7 ]
Nader, Karim [8 ]
Sun, Hongyu [4 ]
De Felice, Fernanda G. [1 ,9 ,10 ,11 ]
Lourenco, Mychael V. [1 ]
Arancio, Ottavio [2 ]
Aguilar-Valles, Argel [4 ]
Sonenberg, Nahum [3 ]
Ferreira, Sergio T. [1 ,11 ,12 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil
[2] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA
[3] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada
[4] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada
[5] Fluminense Fed Univ, Biomed Inst, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil
[6] Univ Montreal, Ctr Interdisciplinary Res Brain & Learning, Dept Neurosci, Montreal, PQ, Canada
[7] Res Grp Neural Signaling & Circuits, Montreal, PQ, Canada
[8] McGill Univ, Dept Psychol, Montreal, PQ, Canada
[9] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Kingston, ON, Canada
[10] Queens Univ, Dept Psychiat, Kingston, ON, Canada
[11] D Or Inst Res & Educ, Rio De Janeiro, RJ, Brazil
[12] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil
关键词
Alzheimer's disease; hydroxynorketamine; memory; mRNA translation; synaptic plasticity; DEPRESSIVE-LIKE BEHAVIOR; AMYLOID-BETA OLIGOMERS; MAMMALIAN TARGET; INHIBITION; DEFICITS; HYDROXYNORKETAMINE; PHOSPHORYLATION; DYSFUNCTION; ACTIVATION; IMPAIRMENT;
D O I
10.1002/alz.14034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: Impaired brain protein synthesis, synaptic plasticity, and memory are major hallmarks of Alzheimer's disease (AD). The ketamine metabolite (2R,6R)-hydroxynorketamine (HNK) has been shown to modulate protein synthesis, but its effects on memory in AD models remain elusive. METHODS: We investigated the effects of HNK on hippocampal protein synthesis, long-term potentiation (LTP), and memory in AD mouse models. RESULTS: HNK activated extracellular signal-regulated kinase 1/2 (ERK1/2), mechanistic target of rapamycin (mTOR), and p70S6 kinase 1 (S6K1)/ribosomal protein S6 signaling pathways. Treatment with HNK rescued hippocampal LTP and memory deficits in amyloid-beta oligomers (A beta O)-infused mice in an ERK1/2-dependent manner. Treatment with HNK further corrected aberrant transcription, LTP and memory in aged APP/PS1 mice. DISCUSSION: Our findings demonstrate that HNK induces signaling and transcriptional responses that correct synaptic and memory deficits in AD mice. These results raise the prospect that HNK could serve as a therapeutic approach in AD.
引用
收藏
页码:5398 / 5410
页数:13
相关论文
共 43 条
  • [41] Blockade of adenosine A2A receptors reverses early spatial memory defects in the APP/PS1 mouse model of Alzheimer’s disease by promoting synaptic plasticity of adult-born granule cells
    Qi Ji
    Yang Yang
    Yun Xiong
    Ying-Jie Zhang
    Jun Jiang
    Li-Ping Zhou
    Xiao-Hui Du
    Chun-Xiang Wang
    Zhi-Ru Zhu
    Alzheimer's Research & Therapy, 15
  • [42] Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease
    Reick, Christiane
    Ellrichmann, Gisa
    Tsai, Teresa
    Lee, De-Hyung
    Wiese, Stefan
    Gold, Ralf
    Saft, Carsten
    Linker, Ralf A.
    EXPERIMENTAL NEUROLOGY, 2016, 285 : 12 - 23
  • [43] The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl] (2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease
    Meunier, Johann
    Villard, Vanessa
    Givalois, Laurent
    Maurice, Tangui
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) : 193 - 199